Characterizing industry payments for FDA-approved AI medical devices
Industry payments for AIMDs are increasing and concentrated among technology-intensive specialties. Payments are more likely to flow to clinicians affiliated with teaching hospitals that are larger and in non-rural areas. This may reflect or mediate increased AI utilization in these settings. Continued monitoring of payments, transparent reporting, and targeted resource support may be needed to promote equitable access to AIMDs.
Authors
- Alon Bergman (ORCID: https://orcid.org/0000-0003-4228-8543)
- Tej A. Patel (ORCID: https://orcid.org/0000-0002-0882-2960)
- Kaustav P. Shah (ORCID: https://orcid.org/0000-0001-6866-0003)
Institutions
- University of Oxford (GB)
- Philadelphia VA Medical Center (US)
- Institute of Medical Ethics (GB)
- Leonard Cheshire (GB)
- University of Pennsylvania (US)
Publication Details
- Journal
- Health Affairs Scholar
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1093/haschl/qxaf211
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00